Baker Brothers Advisors - INOTEK PHARMACEUTICALS CORP ownership

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of INOTEK PHARMACEUTICALS CORP
ValueSharesWeighting
Q1 2018$4,795,000
+19.6%
5,000,0000.0%0.04%
+17.1%
Q4 2017$4,009,000
+2.7%
5,000,0000.0%0.04%
+9.4%
Q3 2017$3,904,000
+31.1%
5,000,0000.0%0.03%
+23.1%
Q2 2017$2,978,000
-1.0%
5,000,0000.0%0.03%
+4.0%
Q1 2017$3,008,000
-41.8%
5,000,0000.0%0.02%
-51.0%
Q4 2016$5,167,000
-23.0%
5,000,0000.0%0.05%
-16.4%
Q3 2016$6,708,0005,000,0000.06%
Other shareholders

There were no reported owners of INOTEK PHARMACEUTICALS CORP in Q3 2023.

NameSharesValueWeighting ↓
View complete list of INOTEK PHARMACEUTICALS CORP shareholders